Revealing the invisible disease causing heart attacks
Our award winning technology is built on almost a decade of academic research from leading institutes
We use commonly available imaging methods in new ways to reveal the features of coronary plaque that can cause heart attack
Coronary Artery Disease
Mosaic uses deep learning to rapidly analyse coronary CT angiography scans
This not only provides a detailed assessment of the coronary arteries and any plaque present, but also the microcalcification activity
Patients with high microcalcification activity have a 7-fold increased risk of heart attack[1]
Apricot uses deep learning and biomechanics to analyse intravascular optical coherence tomography (OCT) scans
This removes the manual processing needed to interpret OCT scans and also provides an assessment of the residual risk of heart attack after treatment
The software also determines the microcalcification activity of the patient
Spun out from a decade research at University of Western Australia and Harry Perkins Institute of Medical Research
A team of biomedical engineers and cardiologist at VascLab have spent several years researching innovative ways improve the treatment of heart disease
In mid 2021 the company Navier Medical was spun out of a partnership between the Harry Perkins Institute of Medical Research and the University of Western Australia
Associate Professor Barry Doyle and his team created Navier Medical to commercialize the Apricot and Mosaic technology
